Trending now
Huawei Brings Embedded Intelligence and Built-in Resilience…
Reimagining finance: DIFC to convene global leaders…
Carziqo Brings ER-BX Autonomous Ride-Hailing Series to…
Sky-Blue Strengthens Global Airline Support with Purpose-Driven…
Gita Sankano Calls on Legal Professionals to…
Linked Helper Unveils Major Autumn 2026 Update…
Dozen K Leaguers named to Moreno’s 1st…
Can Chinese entertainment surpass Korean wave in…
Finance minister nominee backs January crypto tax…
GM plans U.S. battery development as Trump’s…
Home
News
Business
National
Press Release
Finanace
Search for:
Search
Primary Menu
Search for:
Search
Home
Business
FDA vaccine head will step down in April after string of controversial decisions
Business
FDA vaccine head will step down in April after string of controversial decisions
by
Douglas L. Grider
Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research.
previous post
FDA reversals leave investors worrying about the fates of other experimental drugs
next post
[TEST DRIVE] Renault Korea’s Filante set to take on Santa Fe, Sorento
Douglas L. Grider
Related posts
Jamie Dimon says Anthropic’s Mythos reveals ‘a lot more vulnerabilities’ for cyberattacks
Douglas L. Grider
April 14, 2026
I drove Tesla FSD, Rivian Autonomy+ ‘hands-free’ driving systems. Here’s how they compare
Douglas L. Grider
August 15, 2026
Citigroup is set to report earnings before the bell
Douglas L. Grider
January 14, 2026
